Chromosome Analysis, Body Fluid
Cytochrome P450 6A2 (CYP6A2) Genotyping
Homocysteine, Urine
Oncomine Dx (CDx)
Glipizide, Urine
Mercury, Random, Urine
N-Telopeptide, Cross-Linked
Anti-SARS-CoV-2 (Coronavirus), IgM
HIV Drug Resistance Phenotyping Assay (Phenosense)
Adenosine Deaminase, RBC
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
Overview
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now